Peter C. Appelbaum
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria 123
- Microbiology top 0.05%
- Bacterial Infections and Vaccines 25
- Clinical Biochemistry top 0.05%
- Bacterial Identification and Susceptibility Testing 90
- Infectious Diseases top 0.1%
- Antimicrobial Resistance in Staphylococcus 130
-
- Pneumonia and Respiratory Infections 165
- Pneumocystis jirovecii pneumonia detection and treatment 31
-
- Antibiotics Pharmacokinetics and Efficacy 156
-
- Streptococcal Infections and Treatments 40
- Co-authors
- Michael R. JacobsGlenn A. PankuchBülent BozdoğanS K SpanglerLois M. EdnieTodd A. DaviesPamela HunterGengrong Lin
- Journals
- Antimicrobial Agents and Chemotherapy (161 papers)Journal of Clinical Microbiology (32 papers)Journal of Antimicrobial Chemotherapy (25 papers)
- Partner nations
- United StatesSouth AfricaGreece
In The Last Decade
Peter C. Appelbaum
369 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Molecular Medicine 4.2k
- Applied Microbiology and Biotechnology 893
- Microbiology 2.7k
- Clinical Biochemistry 2.4k
- Infectious Diseases 5.5k
Countries citing papers authored by Peter C. Appelbaum
This map shows the geographic impact of Peter C. Appelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Appelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Appelbaum more than expected).
Fields of papers citing papers by Peter C. Appelbaum
This network shows the impact of papers produced by Peter C. Appelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Appelbaum. The network helps show where Peter C. Appelbaum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter C. Appelbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2009 | 53 | |
| 4 | 2008 | 15 | |
| 5 | 2005 | 51 | |
| 6 | 2005 | 4 | |
| 7 | 2004 | 6 | |
| 8 | 2003 | 6 | |
| 9 | 2003 | 15 | |
| 10 | 2002 | 10 | |
| 11 | 2002 | 6 | |
| 12 | Gemifloxacin : potency and performance | 2000 | 1 |
| 13 | 2000 | 8 | |
| 14 | 1995 | 22 | |
| 15 | 1993 | 50 | |
| 16 | 1990 | 24 | |
| 17 | Susceptibility of non-fermentative bacteria to ten antimicrobial agents | 1982 | 1 |
| 18 | 1982 | 25 | |
| 19 | Metronidazole in the prophylaxis and treatment of anaerobic infection. | 1978 | 19 |
| 20 | 1978 | 20 |
About Peter C. Appelbaum
Peter C. Appelbaum is a scholar working on Molecular Medicine, Clinical Biochemistry, Pharmacology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 374 papers that have together received 15.6k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (165 papers), Antibiotics Pharmacokinetics and Efficacy (156 papers), Antimicrobial Resistance in Staphylococcus (130 papers), Antibiotic Resistance in Bacteria (123 papers), Bacterial Identification and Susceptibility Testing (90 papers), Streptococcal Infections and Treatments (40 papers), Pneumocystis jirovecii pneumonia detection and treatment (31 papers) and Bacterial Infections and Vaccines (25 papers). The work is most often cited by research in Molecular Medicine (4.2k citations), Applied Microbiology and Biotechnology (893 citations), Microbiology (2.7k citations), Clinical Biochemistry (2.4k citations) and Infectious Diseases (5.5k citations). Peter C. Appelbaum has collaborated with scholars based in United States, South Africa and Greece. Frequent co-authors include Michael R. Jacobs, Glenn A. Pankuch, Bülent Bozdoğan, S K Spangler, Lois M. Ednie, Todd A. Davies, Pamela Hunter, Gengrong Lin, Klaudia Kosowska-Shick and Saralee Bajaksouzian. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.